IL-6 is proposed to be secreted from CAFs of this tumour, inducing epigenetic changes in cholangiocytes and thereby enforcing a malignant transformation driving the initiation of intrahepatic cholangiocarcinoma [80]. Here, IL6 is linked to neoplasm.